Bipolar transurethral enucleation of prostate versus photoselective vaporization for symptomatic ben

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:yuhuile
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
We prospectively compared the safety and efficacy of bipolar transurethral enucleation of the prostate (TUEP) versus 160?W lithium triboride laser (LBO) photoselective vaporization of the prostate (PVP) for treating benign prostatic hyperplasia >70 ml. Between February 2011 and December 2013, we treated 81 patients with benign prostatic hyperplasia >70 ml (39 using bipolar TUEP, 42 using PVP).
其他文献
Prostatecancer is aleading cause of cancer death in men.Despite recent advances in our understanding and treatment of advanced disease,no systemic therapy is curative and new therapies are needed.Targeting angiogenesis is an attractive therapeutic strateg
期刊
@@
The introduction of nerve-sparing technique is one of the most significant advances in the surgical treatment of prostate cancer and heralded a shift from a curing cancer at all-cost model to a curing cancer and preserving quality of life model?,2 In a re
期刊
@@
期刊
In 2004, docetaxel was approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). For the next several years, there was a lull in drug approvals. However, from 2010 onwards, 5 additional therapies have been approved on the basi
This case?controlled study was designed to evaluate the association between various baseline parental factors and the risk of hypospadias in China. Patients were selected from tertiary referral hospitals in Anhui, a province in mid?eastern China. Aquestio